Intravitreal injection of autologous plasmin enzyme for macular edema associated with branch retinal vein occlusion.

摘要

WE READ WITH SPECIAL INTEREST THE ARTICLE BY SAKUMA and associates describing the results of intravitreal autologous plasmin enzyme for macular edema in branch vein occlusion. Our clinical research has focused on the treatment of retinal disorders with autologous plasmin enzyme (APE) for the last 4 years. We have already published the favorable results obtained with APE in the management of diabetic macular edema and vitreomacular traction syndrome. In our research we have also treated cases of macular edema secondary to branch vein occlusion where the vitreous was still attached to the retina, and this seemed to be the cause of the persistence of the edema or its worsening.